We also analyzed the expression patterns of PRMT subtypes in patients with breast cancer, and the results validated that PRMT1, PRMT2 and PRMT4 were elevated in patients with TNBC compared with levels in those with non-TNBC (Figure 4D). Here, CARM1 is linked to breast carcinoma.